Ischemic heart disease is the most frequent cause of out-of-hospital cardiac arrest, a leading cause of death in Europe and the United States. The COACT (Coronary Angiography after Cardiac Arrest) trial investigated whether immediate angiography after resuscitation from cardiac arrest would have better outcome as compared to delayed angiography in terms of overall survival at … [Read more...] about COACT trial: Immediate vs delayed angiography in non-STEMI patients after cardiac arrest
Cardiology research news
COVID-19 and Cardiovascular Complications
It has become apparent that unlike other coronaviruses, COVID-19 can impact the heart and lead to cardiovascular disease. Individuals with pre-existing heart disease are at greater risk to mortality if infected with COVID-19. Hereby, we review: What is known about the link between COVID-19 and the heart?COVID-19 and the risk of cardiovascular complicationsCase report of a … [Read more...] about COVID-19 and Cardiovascular Complications
COVID-19 and the Heart
What is the impact of coronavirus on the heart? A novel coronavirus, initially named 2019-nCoV, caused the outbreak of pneumonia in December 2019 in Wuhan, China. The virus was renamed “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2) by the WHO and is now known as COVID-19. Compared to the SARS-CoV that caused SARS in 2003, SARS-CoV-2 has a stronger … [Read more...] about COVID-19 and the Heart
The ISCHEMIA trial: surgery fails to beat optimal medical therapy
https://youtu.be/ThCxKSd6Vls The results of the ISCHEMIA1 trial were presented recently at the American Heart Association’s scientific sessions. This was the largest-ever randomized trial comparing invasive and conservative strategies in patients with stable ischemic heart disease. The findings indicate that routine percutaneous coronary intervention (PCI) does not … [Read more...] about The ISCHEMIA trial: surgery fails to beat optimal medical therapy
Renin-angiotensin system inhibitors improve TAVR prognosis
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace narrowed aortic valves that fail to properly open. Following this procedure, however, left ventricular (LV) hypertrophy and myocardial fibrosis persist and are linked to worse prognosis. Renin-angiotensin system (RAS) inhibition can protect against these risks and in response to … [Read more...] about Renin-angiotensin system inhibitors improve TAVR prognosis